Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

MCL1 and BCL-xL levels in solid tumors are predictive of dinaciclib-induced apoptosis.

Booher RN, Hatch H, Dolinski BM, Nguyen T, Harmonay L, Al-Assaad AS, Ayers M, Nebozhyn M, Loboda A, Hirsch HA, Zhang T, Shi B, Merkel CE, Angagaw MH, Wang Y, Long BJ, Lennon XQ, Miselis N, Pucci V, Monahan JW, Lee J, Kondic AG, Im EK, Mauro D, Blanchard R, Gilliland G, Fawell SE, Zawel L, Schuller AG, Strack P.

PLoS One. 2014 Oct 7;9(10):e108371. doi: 10.1371/journal.pone.0108371. eCollection 2014.

2.

Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice.

Bian F, Nath R, Sobocinski G, Booher RN, Lipinski WJ, Callahan MJ, Pack A, Wang KK, Walker LC.

J Comp Neurol. 2002 May 6;446(3):257-66.

PMID:
11932941
3.

Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator.

Wang Y, Li J, Booher RN, Kraker A, Lawrence T, Leopold WR, Sun Y.

Cancer Res. 2001 Nov 15;61(22):8211-7.

4.

Binding of 14-3-3beta to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2-M cell population.

Wang Y, Jacobs C, Hook KE, Duan H, Booher RN, Sun Y.

Cell Growth Differ. 2000 Apr;11(4):211-9.

5.

Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity.

Booher RN, Holman PS, Fattaey A.

J Biol Chem. 1997 Aug 29;272(35):22300-6.

6.

Myt1: a Wee1-type kinase that phosphorylates Cdc2 on residue Thr14.

Fattaey A, Booher RN.

Prog Cell Cycle Res. 1997;3:233-40. Review.

PMID:
9552418
7.

Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity.

Foreman MM, Fuller RW, Rasmussen K, Nelson DL, Calligaro DO, Zhang L, Barrett JE, Booher RN, Paget CJ Jr, Flaugh ME.

J Pharmacol Exp Ther. 1994 Sep;270(3):1270-81.

PMID:
7523657
8.
9.

cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2.

Gautier J, Solomon MJ, Booher RN, Bazan JF, Kirschner MW.

Cell. 1991 Oct 4;67(1):197-211.

PMID:
1913817
10.

The fission yeast cdc2/cdc13/suc1 protein kinase: regulation of catalytic activity and nuclear localization.

Booher RN, Alfa CE, Hyams JS, Beach DH.

Cell. 1989 Aug 11;58(3):485-97.

PMID:
2569363
11.

Synthesis of D-oxa tricyclic partial ergolines as dopamine agonists.

Booher RN, Kornfeld EC, Smalstig EB, Clemens JA.

J Med Chem. 1987 Mar;30(3):580-3.

PMID:
3102743
12.

Preclinical pharmacology of doxpicodin, a new analgesic.

Smits SE, Nickander R, Booher RN, Zimmerman DM, Wong DT, Hynes MD, Pohland A.

NIDA Res Monogr. 1981 Feb;34:75-81. No abstract available.

PMID:
6261137
13.

Synthesis of two metabolites of (+)-propoxyphene.

Turner WW, Booher RN, Smits SE, Pohland A.

J Med Chem. 1977 Aug;20(8):1065-8.

PMID:
894676
14.

Various 5-substituted and 2,5-disubstituted 1,3-dioxanes, a new class of analgesic agents.

Booher RN, Smits SE, Turner WW Jr, Pohland A.

J Med Chem. 1977 Jul;20(7):885-90.

PMID:
874963
15.

Synthesis of a new metabolite of acetylmethadol.

Booher RN, Pohland A.

J Med Chem. 1975 Mar;18(3):266-8.

PMID:
1133816
16.

Synthesis of acronycine.

Beck JR, Kwok R, Booher RN, Brown AC, Patterson LE, Pranc P, Rockey B, Pohland A.

J Am Chem Soc. 1968 Aug 14;90(17):4706-10. No abstract available.

PMID:
5661139
17.

Synthesis of acronycine.

Beck JR, Booher RN, Brown AC, Kwok R, Pohland A.

J Am Chem Soc. 1967 Jul 19;89(15):3934-5. No abstract available.

PMID:
6043828

Supplemental Content

Loading ...
Support Center